These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10586194)

  • 21. Global ischemia impairs ATP-sensitive K+ channel function in cerebral arterioles in piglets.
    Bari F; Louis TM; Meng W; Busija DW
    Stroke; 1996 Oct; 27(10):1874-80; discussion 1880-1. PubMed ID: 8841347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis.
    Moreau R; Komeichi H; Kirstetter P; Ohsuga M; Cailmail S; Lebrec D
    Gastroenterology; 1994 Apr; 106(4):1016-23. PubMed ID: 8143968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATP-sensitive K+ channels mediate dilatation of cerebral arterioles during hypoxia.
    Taguchi H; Heistad DD; Kitazono T; Faraci FM
    Circ Res; 1994 May; 74(5):1005-8. PubMed ID: 8156623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preservation of myocyte contractile function after hyperthermic cardioplegic arrest by activation of ATP-sensitive potassium channels.
    Dorman BH; Hebbar L; Hinton RB; Roy RC; Spinale FG
    Circulation; 1997 Oct; 96(7):2376-84. PubMed ID: 9337214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of vasoconstriction by potassium channel opener aprikalim in human conduit arteries used as bypass grafts.
    He GW; Yang CQ
    Br J Clin Pharmacol; 1997 Oct; 44(4):353-9. PubMed ID: 9354310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cold cardioplegia and the K+ channel modulator aprikalim (RP 52891): improved cardioprotection in isolated ischemic rabbit hearts.
    Pignac J; Bourgouin J; Dumont L
    Can J Physiol Pharmacol; 1994 Feb; 72(2):126-32. PubMed ID: 8050052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein.
    Longmore J; Newgreen DT; Weston AH
    Eur J Pharmacol; 1990 Nov; 190(1-2):75-84. PubMed ID: 1706274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
    Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial potassium channel opener diazoxide preserves neuronal-vascular function after cerebral ischemia in newborn pigs.
    Domoki F; Perciaccante JV; Veltkamp R; Bari F; Busija DW
    Stroke; 1999 Dec; 30(12):2713-8; discussion 2718-9. PubMed ID: 10583002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotective actions of potassium channel openers.
    Auchampach JA; Maruyama M; Gross GJ
    Eur Heart J; 1994 Aug; 15 Suppl C():89-94. PubMed ID: 7995278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergism of the malononitrilamides 279 and 715 with cyclosporine A in the induction of long-term cardiac allograft survival.
    Lindner JK; Zantl N
    Transpl Int; 1998; 11 Suppl 1():S303-9. PubMed ID: 9665002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two different types of potassium channels in human skeletal muscle activated by potassium channel openers.
    Quasthoff S; Franke C; Hatt H; Richter-Turtur M
    Neurosci Lett; 1990 Nov; 119(2):191-4. PubMed ID: 2126363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible involvement of K(ATP) channels in the control of 5-HT neurons.
    Haj-Dahmane S; Laporte AM; Vantalon V; Fattaccini CM; Hamon M; Lanfumey L
    Brain Res; 1993 Jun; 614(1-2):270-8. PubMed ID: 8394188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes.
    Escande D; Thuringer D; Le Guern S; Courteix J; Laville M; Cavero I
    Pflugers Arch; 1989 Sep; 414(6):669-75. PubMed ID: 2510125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of potassium channel opener aprikalim on the receptor-mediated vasoconstriction in the human internal mammary artery.
    Liu MH; Floten HS; Furnary AP; Yim AP; He GW
    Ann Thorac Surg; 2001 Feb; 71(2):636-41. PubMed ID: 11235720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels.
    Miura H; Wachtel RE; Loberiza FR; Saito T; Miura M; Nicolosi AC; Gutterman DD
    Circ Res; 2003 Feb; 92(2):151-8. PubMed ID: 12574142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolongation of rat heart allograft survival using cyclosporine and enisoprost, a prostaglandin E1 analog.
    Fabrega AJ; Blanchard J; Rivas PA; Moran SM; Pollak R
    Transplantation; 1992 Jun; 53(6):1363-4. PubMed ID: 1604492
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of effects of aprikalim and of hypoxic and ischaemic preconditioning on extracellular potassium accumulation, metabolism, and functional recovery of the globally ischaemic rat heart.
    Guo AC; Diacono J; Feuvray D
    Cardiovasc Res; 1994 Jun; 28(6):864-71. PubMed ID: 7923293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful experimental heart transplantation without immunosuppressive drugs.
    Kline GM; Shen Z; Mohiuddin M; Ruggiero V; Rostami S; DiSesa VJ
    J Heart Lung Transplant; 1993; 12(3):388-93. PubMed ID: 8329408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.